Pay in 4 interest-free payments of $7.19 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
In many cases patients will have difficulty if any antimicrobials are given before the full binding protocol has been implemented
It was also categorized as a substance with significant safety concerns and is not currently approved for routine compounding under 503A
Schisandrin B: a dual inhibitor of p-glycoprotein and multidrug resistance-associated protein 1
Kim YB, Lee YH, Park SJ, Choi HJ
The initial consultation, required lab work, follow-up visit frequency, and whether the program includes medication costs or bills them separately all influence total cost
The compounding pharmacy workaround to address a medication shortage is helpful, as long as its done properly
US$ 26.96
US$ 23.31
US$ 28.26
US$ 24.00
